Global Drug Delivery Devices Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
According to APO Research, The global Drug Delivery Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Drug Delivery Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drug Delivery Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Drug Delivery Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drug Delivery Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drug Delivery Devices include Cipla, Baxter International, Nipro Corporation, Roche, Boehringer Ingelheim, Allergan, 3M, BD and Catalent, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Drug Delivery Devices, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drug Delivery Devices, also provides the value of main regions and countries. Of the upcoming market potential for Drug Delivery Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug Delivery Devices revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Drug Delivery Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Drug Delivery Devices company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Drug Delivery Devices segment by Company
1. To analyze and research the global Drug Delivery Devices status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Drug Delivery Devices key companies, revenue, market share, and recent developments.
3. To split the Drug Delivery Devices breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Drug Delivery Devices market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Drug Delivery Devices significant trends, drivers, influence factors in global and regions.
6. To analyze Drug Delivery Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Delivery Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Delivery Devices industry.
Chapter 3: Detailed analysis of Drug Delivery Devices company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Drug Delivery Devices in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
According to APO Research, The global Drug Delivery Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Drug Delivery Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drug Delivery Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Drug Delivery Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drug Delivery Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drug Delivery Devices include Cipla, Baxter International, Nipro Corporation, Roche, Boehringer Ingelheim, Allergan, 3M, BD and Catalent, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Drug Delivery Devices, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drug Delivery Devices, also provides the value of main regions and countries. Of the upcoming market potential for Drug Delivery Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug Delivery Devices revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Drug Delivery Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Drug Delivery Devices company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Drug Delivery Devices segment by Company
- Cipla
- Baxter International
- Nipro Corporation
- Roche
- Boehringer Ingelheim
- Allergan
- 3M
- BD
- Catalent
- Valeant Pharmaceuticals
- Bayer AG
- Chiesi
- Phillips-Medisize
- Johnson & Johnson
- Shandong Weigao
- Pfizer
- B.Braun
- Novartis AG
- Zhengkang
- Gerresheimer
- COVIDIEN Medtronic
- Schott forma vitrum
- Alkermes
- Skyepharma
- Injection Type
- Mucosal Type
- Implanted Type
- Others Type
- Pharmaceutical Companies
- Hospitals
- Clinics
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Drug Delivery Devices status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Drug Delivery Devices key companies, revenue, market share, and recent developments.
3. To split the Drug Delivery Devices breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Drug Delivery Devices market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Drug Delivery Devices significant trends, drivers, influence factors in global and regions.
6. To analyze Drug Delivery Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Delivery Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Delivery Devices industry.
Chapter 3: Detailed analysis of Drug Delivery Devices company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Drug Delivery Devices in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Drug Delivery Devices Market Size, 2019 VS 2023 VS 2030
1.3 Global Drug Delivery Devices Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 DRUG DELIVERY DEVICES MARKET DYNAMICS
2.1 Drug Delivery Devices Industry Trends
2.2 Drug Delivery Devices Industry Drivers
2.3 Drug Delivery Devices Industry Opportunities and Challenges
2.4 Drug Delivery Devices Industry Restraints
3 DRUG DELIVERY DEVICES MARKET BY COMPANY
3.1 Global Drug Delivery Devices Company Revenue Ranking in 2023
3.2 Global Drug Delivery Devices Revenue by Company (2019-2024)
3.3 Global Drug Delivery Devices Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Drug Delivery Devices Company Manufacturing Base & Headquarters
3.5 Global Drug Delivery Devices Company, Product Type & Application
3.6 Global Drug Delivery Devices Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Drug Delivery Devices Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Drug Delivery Devices Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 DRUG DELIVERY DEVICES MARKET BY TYPE
4.1 Drug Delivery Devices Type Introduction
4.1.1 Injection Type
4.1.2 Mucosal Type
4.1.3 Implanted Type
4.1.4 Others Type
4.2 Global Drug Delivery Devices Sales Value by Type
4.2.1 Global Drug Delivery Devices Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Drug Delivery Devices Sales Value by Type (2019-2030)
4.2.3 Global Drug Delivery Devices Sales Value Share by Type (2019-2030)
5 DRUG DELIVERY DEVICES MARKET BY APPLICATION
5.1 Drug Delivery Devices Application Introduction
5.1.1 Pharmaceutical Companies
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 Global Drug Delivery Devices Sales Value by Application
5.2.1 Global Drug Delivery Devices Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Drug Delivery Devices Sales Value by Application (2019-2030)
5.2.3 Global Drug Delivery Devices Sales Value Share by Application (2019-2030)
6 DRUG DELIVERY DEVICES MARKET BY REGION
6.1 Global Drug Delivery Devices Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Drug Delivery Devices Sales Value by Region (2019-2030)
6.2.1 Global Drug Delivery Devices Sales Value by Region: 2019-2024
6.2.2 Global Drug Delivery Devices Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Drug Delivery Devices Sales Value (2019-2030)
6.3.2 North America Drug Delivery Devices Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drug Delivery Devices Sales Value (2019-2030)
6.4.2 Europe Drug Delivery Devices Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Drug Delivery Devices Sales Value (2019-2030)
6.5.2 Asia-Pacific Drug Delivery Devices Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Drug Delivery Devices Sales Value (2019-2030)
6.6.2 Latin America Drug Delivery Devices Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Drug Delivery Devices Sales Value (2019-2030)
6.7.2 Middle East & Africa Drug Delivery Devices Sales Value Share by Country, 2023 VS 2030
7 DRUG DELIVERY DEVICES MARKET BY COUNTRY
7.1 Global Drug Delivery Devices Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Drug Delivery Devices Sales Value by Country (2019-2030)
7.2.1 Global Drug Delivery Devices Sales Value by Country (2019-2024)
7.2.2 Global Drug Delivery Devices Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.3.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.4.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.5.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.6.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.7.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.8.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.9.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.10.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.11.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.12.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.13.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.14.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.15.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.16.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.17.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.18.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.19.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.20.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.21.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Cipla
8.1.1 Cipla Comapny Information
8.1.2 Cipla Business Overview
8.1.3 Cipla Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.1.4 Cipla Drug Delivery Devices Product Portfolio
8.1.5 Cipla Recent Developments
8.2 Baxter International
8.2.1 Baxter International Comapny Information
8.2.2 Baxter International Business Overview
8.2.3 Baxter International Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.2.4 Baxter International Drug Delivery Devices Product Portfolio
8.2.5 Baxter International Recent Developments
8.3 Nipro Corporation
8.3.1 Nipro Corporation Comapny Information
8.3.2 Nipro Corporation Business Overview
8.3.3 Nipro Corporation Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.3.4 Nipro Corporation Drug Delivery Devices Product Portfolio
8.3.5 Nipro Corporation Recent Developments
8.4 Roche
8.4.1 Roche Comapny Information
8.4.2 Roche Business Overview
8.4.3 Roche Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.4.4 Roche Drug Delivery Devices Product Portfolio
8.4.5 Roche Recent Developments
8.5 Boehringer Ingelheim
8.5.1 Boehringer Ingelheim Comapny Information
8.5.2 Boehringer Ingelheim Business Overview
8.5.3 Boehringer Ingelheim Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.5.4 Boehringer Ingelheim Drug Delivery Devices Product Portfolio
8.5.5 Boehringer Ingelheim Recent Developments
8.6 Allergan
8.6.1 Allergan Comapny Information
8.6.2 Allergan Business Overview
8.6.3 Allergan Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.6.4 Allergan Drug Delivery Devices Product Portfolio
8.6.5 Allergan Recent Developments
8.7 3M
8.7.1 3M Comapny Information
8.7.2 3M Business Overview
8.7.3 3M Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.7.4 3M Drug Delivery Devices Product Portfolio
8.7.5 3M Recent Developments
8.8 BD
8.8.1 BD Comapny Information
8.8.2 BD Business Overview
8.8.3 BD Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.8.4 BD Drug Delivery Devices Product Portfolio
8.8.5 BD Recent Developments
8.9 Catalent
8.9.1 Catalent Comapny Information
8.9.2 Catalent Business Overview
8.9.3 Catalent Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.9.4 Catalent Drug Delivery Devices Product Portfolio
8.9.5 Catalent Recent Developments
8.10 Valeant Pharmaceuticals
8.10.1 Valeant Pharmaceuticals Comapny Information
8.10.2 Valeant Pharmaceuticals Business Overview
8.10.3 Valeant Pharmaceuticals Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.10.4 Valeant Pharmaceuticals Drug Delivery Devices Product Portfolio
8.10.5 Valeant Pharmaceuticals Recent Developments
8.11 Bayer AG
8.11.1 Bayer AG Comapny Information
8.11.2 Bayer AG Business Overview
8.11.3 Bayer AG Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.11.4 Bayer AG Drug Delivery Devices Product Portfolio
8.11.5 Bayer AG Recent Developments
8.12 Chiesi
8.12.1 Chiesi Comapny Information
8.12.2 Chiesi Business Overview
8.12.3 Chiesi Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.12.4 Chiesi Drug Delivery Devices Product Portfolio
8.12.5 Chiesi Recent Developments
8.13 Phillips-Medisize
8.13.1 Phillips-Medisize Comapny Information
8.13.2 Phillips-Medisize Business Overview
8.13.3 Phillips-Medisize Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.13.4 Phillips-Medisize Drug Delivery Devices Product Portfolio
8.13.5 Phillips-Medisize Recent Developments
8.14 Johnson & Johnson
8.14.1 Johnson & Johnson Comapny Information
8.14.2 Johnson & Johnson Business Overview
8.14.3 Johnson & Johnson Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.14.4 Johnson & Johnson Drug Delivery Devices Product Portfolio
8.14.5 Johnson & Johnson Recent Developments
8.15 Shandong Weigao
8.15.1 Shandong Weigao Comapny Information
8.15.2 Shandong Weigao Business Overview
8.15.3 Shandong Weigao Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.15.4 Shandong Weigao Drug Delivery Devices Product Portfolio
8.15.5 Shandong Weigao Recent Developments
8.16 Pfizer
8.16.1 Pfizer Comapny Information
8.16.2 Pfizer Business Overview
8.16.3 Pfizer Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.16.4 Pfizer Drug Delivery Devices Product Portfolio
8.16.5 Pfizer Recent Developments
8.17 B.Braun
8.17.1 B.Braun Comapny Information
8.17.2 B.Braun Business Overview
8.17.3 B.Braun Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.17.4 B.Braun Drug Delivery Devices Product Portfolio
8.17.5 B.Braun Recent Developments
8.18 Novartis AG
8.18.1 Novartis AG Comapny Information
8.18.2 Novartis AG Business Overview
8.18.3 Novartis AG Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.18.4 Novartis AG Drug Delivery Devices Product Portfolio
8.18.5 Novartis AG Recent Developments
8.19 Zhengkang
8.19.1 Zhengkang Comapny Information
8.19.2 Zhengkang Business Overview
8.19.3 Zhengkang Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.19.4 Zhengkang Drug Delivery Devices Product Portfolio
8.19.5 Zhengkang Recent Developments
8.20 Gerresheimer
8.20.1 Gerresheimer Comapny Information
8.20.2 Gerresheimer Business Overview
8.20.3 Gerresheimer Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.20.4 Gerresheimer Drug Delivery Devices Product Portfolio
8.20.5 Gerresheimer Recent Developments
8.21 COVIDIEN Medtronic
8.21.1 COVIDIEN Medtronic Comapny Information
8.21.2 COVIDIEN Medtronic Business Overview
8.21.3 COVIDIEN Medtronic Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.21.4 COVIDIEN Medtronic Drug Delivery Devices Product Portfolio
8.21.5 COVIDIEN Medtronic Recent Developments
8.22 Schott forma vitrum
8.22.1 Schott forma vitrum Comapny Information
8.22.2 Schott forma vitrum Business Overview
8.22.3 Schott forma vitrum Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.22.4 Schott forma vitrum Drug Delivery Devices Product Portfolio
8.22.5 Schott forma vitrum Recent Developments
8.23 Alkermes
8.23.1 Alkermes Comapny Information
8.23.2 Alkermes Business Overview
8.23.3 Alkermes Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.23.4 Alkermes Drug Delivery Devices Product Portfolio
8.23.5 Alkermes Recent Developments
8.24 Skyepharma
8.24.1 Skyepharma Comapny Information
8.24.2 Skyepharma Business Overview
8.24.3 Skyepharma Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.24.4 Skyepharma Drug Delivery Devices Product Portfolio
8.24.5 Skyepharma Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
1.1 Product Definition
1.2 Global Drug Delivery Devices Market Size, 2019 VS 2023 VS 2030
1.3 Global Drug Delivery Devices Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 DRUG DELIVERY DEVICES MARKET DYNAMICS
2.1 Drug Delivery Devices Industry Trends
2.2 Drug Delivery Devices Industry Drivers
2.3 Drug Delivery Devices Industry Opportunities and Challenges
2.4 Drug Delivery Devices Industry Restraints
3 DRUG DELIVERY DEVICES MARKET BY COMPANY
3.1 Global Drug Delivery Devices Company Revenue Ranking in 2023
3.2 Global Drug Delivery Devices Revenue by Company (2019-2024)
3.3 Global Drug Delivery Devices Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Drug Delivery Devices Company Manufacturing Base & Headquarters
3.5 Global Drug Delivery Devices Company, Product Type & Application
3.6 Global Drug Delivery Devices Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Drug Delivery Devices Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Drug Delivery Devices Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 DRUG DELIVERY DEVICES MARKET BY TYPE
4.1 Drug Delivery Devices Type Introduction
4.1.1 Injection Type
4.1.2 Mucosal Type
4.1.3 Implanted Type
4.1.4 Others Type
4.2 Global Drug Delivery Devices Sales Value by Type
4.2.1 Global Drug Delivery Devices Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Drug Delivery Devices Sales Value by Type (2019-2030)
4.2.3 Global Drug Delivery Devices Sales Value Share by Type (2019-2030)
5 DRUG DELIVERY DEVICES MARKET BY APPLICATION
5.1 Drug Delivery Devices Application Introduction
5.1.1 Pharmaceutical Companies
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 Global Drug Delivery Devices Sales Value by Application
5.2.1 Global Drug Delivery Devices Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Drug Delivery Devices Sales Value by Application (2019-2030)
5.2.3 Global Drug Delivery Devices Sales Value Share by Application (2019-2030)
6 DRUG DELIVERY DEVICES MARKET BY REGION
6.1 Global Drug Delivery Devices Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Drug Delivery Devices Sales Value by Region (2019-2030)
6.2.1 Global Drug Delivery Devices Sales Value by Region: 2019-2024
6.2.2 Global Drug Delivery Devices Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Drug Delivery Devices Sales Value (2019-2030)
6.3.2 North America Drug Delivery Devices Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drug Delivery Devices Sales Value (2019-2030)
6.4.2 Europe Drug Delivery Devices Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Drug Delivery Devices Sales Value (2019-2030)
6.5.2 Asia-Pacific Drug Delivery Devices Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Drug Delivery Devices Sales Value (2019-2030)
6.6.2 Latin America Drug Delivery Devices Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Drug Delivery Devices Sales Value (2019-2030)
6.7.2 Middle East & Africa Drug Delivery Devices Sales Value Share by Country, 2023 VS 2030
7 DRUG DELIVERY DEVICES MARKET BY COUNTRY
7.1 Global Drug Delivery Devices Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Drug Delivery Devices Sales Value by Country (2019-2030)
7.2.1 Global Drug Delivery Devices Sales Value by Country (2019-2024)
7.2.2 Global Drug Delivery Devices Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.3.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.4.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.5.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.6.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.7.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.8.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.9.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.10.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.11.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.12.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.13.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.14.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.15.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.16.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.17.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.18.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.19.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.20.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Drug Delivery Devices Sales Value Growth Rate (2019-2030)
7.21.2 Global Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Cipla
8.1.1 Cipla Comapny Information
8.1.2 Cipla Business Overview
8.1.3 Cipla Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.1.4 Cipla Drug Delivery Devices Product Portfolio
8.1.5 Cipla Recent Developments
8.2 Baxter International
8.2.1 Baxter International Comapny Information
8.2.2 Baxter International Business Overview
8.2.3 Baxter International Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.2.4 Baxter International Drug Delivery Devices Product Portfolio
8.2.5 Baxter International Recent Developments
8.3 Nipro Corporation
8.3.1 Nipro Corporation Comapny Information
8.3.2 Nipro Corporation Business Overview
8.3.3 Nipro Corporation Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.3.4 Nipro Corporation Drug Delivery Devices Product Portfolio
8.3.5 Nipro Corporation Recent Developments
8.4 Roche
8.4.1 Roche Comapny Information
8.4.2 Roche Business Overview
8.4.3 Roche Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.4.4 Roche Drug Delivery Devices Product Portfolio
8.4.5 Roche Recent Developments
8.5 Boehringer Ingelheim
8.5.1 Boehringer Ingelheim Comapny Information
8.5.2 Boehringer Ingelheim Business Overview
8.5.3 Boehringer Ingelheim Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.5.4 Boehringer Ingelheim Drug Delivery Devices Product Portfolio
8.5.5 Boehringer Ingelheim Recent Developments
8.6 Allergan
8.6.1 Allergan Comapny Information
8.6.2 Allergan Business Overview
8.6.3 Allergan Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.6.4 Allergan Drug Delivery Devices Product Portfolio
8.6.5 Allergan Recent Developments
8.7 3M
8.7.1 3M Comapny Information
8.7.2 3M Business Overview
8.7.3 3M Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.7.4 3M Drug Delivery Devices Product Portfolio
8.7.5 3M Recent Developments
8.8 BD
8.8.1 BD Comapny Information
8.8.2 BD Business Overview
8.8.3 BD Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.8.4 BD Drug Delivery Devices Product Portfolio
8.8.5 BD Recent Developments
8.9 Catalent
8.9.1 Catalent Comapny Information
8.9.2 Catalent Business Overview
8.9.3 Catalent Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.9.4 Catalent Drug Delivery Devices Product Portfolio
8.9.5 Catalent Recent Developments
8.10 Valeant Pharmaceuticals
8.10.1 Valeant Pharmaceuticals Comapny Information
8.10.2 Valeant Pharmaceuticals Business Overview
8.10.3 Valeant Pharmaceuticals Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.10.4 Valeant Pharmaceuticals Drug Delivery Devices Product Portfolio
8.10.5 Valeant Pharmaceuticals Recent Developments
8.11 Bayer AG
8.11.1 Bayer AG Comapny Information
8.11.2 Bayer AG Business Overview
8.11.3 Bayer AG Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.11.4 Bayer AG Drug Delivery Devices Product Portfolio
8.11.5 Bayer AG Recent Developments
8.12 Chiesi
8.12.1 Chiesi Comapny Information
8.12.2 Chiesi Business Overview
8.12.3 Chiesi Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.12.4 Chiesi Drug Delivery Devices Product Portfolio
8.12.5 Chiesi Recent Developments
8.13 Phillips-Medisize
8.13.1 Phillips-Medisize Comapny Information
8.13.2 Phillips-Medisize Business Overview
8.13.3 Phillips-Medisize Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.13.4 Phillips-Medisize Drug Delivery Devices Product Portfolio
8.13.5 Phillips-Medisize Recent Developments
8.14 Johnson & Johnson
8.14.1 Johnson & Johnson Comapny Information
8.14.2 Johnson & Johnson Business Overview
8.14.3 Johnson & Johnson Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.14.4 Johnson & Johnson Drug Delivery Devices Product Portfolio
8.14.5 Johnson & Johnson Recent Developments
8.15 Shandong Weigao
8.15.1 Shandong Weigao Comapny Information
8.15.2 Shandong Weigao Business Overview
8.15.3 Shandong Weigao Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.15.4 Shandong Weigao Drug Delivery Devices Product Portfolio
8.15.5 Shandong Weigao Recent Developments
8.16 Pfizer
8.16.1 Pfizer Comapny Information
8.16.2 Pfizer Business Overview
8.16.3 Pfizer Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.16.4 Pfizer Drug Delivery Devices Product Portfolio
8.16.5 Pfizer Recent Developments
8.17 B.Braun
8.17.1 B.Braun Comapny Information
8.17.2 B.Braun Business Overview
8.17.3 B.Braun Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.17.4 B.Braun Drug Delivery Devices Product Portfolio
8.17.5 B.Braun Recent Developments
8.18 Novartis AG
8.18.1 Novartis AG Comapny Information
8.18.2 Novartis AG Business Overview
8.18.3 Novartis AG Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.18.4 Novartis AG Drug Delivery Devices Product Portfolio
8.18.5 Novartis AG Recent Developments
8.19 Zhengkang
8.19.1 Zhengkang Comapny Information
8.19.2 Zhengkang Business Overview
8.19.3 Zhengkang Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.19.4 Zhengkang Drug Delivery Devices Product Portfolio
8.19.5 Zhengkang Recent Developments
8.20 Gerresheimer
8.20.1 Gerresheimer Comapny Information
8.20.2 Gerresheimer Business Overview
8.20.3 Gerresheimer Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.20.4 Gerresheimer Drug Delivery Devices Product Portfolio
8.20.5 Gerresheimer Recent Developments
8.21 COVIDIEN Medtronic
8.21.1 COVIDIEN Medtronic Comapny Information
8.21.2 COVIDIEN Medtronic Business Overview
8.21.3 COVIDIEN Medtronic Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.21.4 COVIDIEN Medtronic Drug Delivery Devices Product Portfolio
8.21.5 COVIDIEN Medtronic Recent Developments
8.22 Schott forma vitrum
8.22.1 Schott forma vitrum Comapny Information
8.22.2 Schott forma vitrum Business Overview
8.22.3 Schott forma vitrum Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.22.4 Schott forma vitrum Drug Delivery Devices Product Portfolio
8.22.5 Schott forma vitrum Recent Developments
8.23 Alkermes
8.23.1 Alkermes Comapny Information
8.23.2 Alkermes Business Overview
8.23.3 Alkermes Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.23.4 Alkermes Drug Delivery Devices Product Portfolio
8.23.5 Alkermes Recent Developments
8.24 Skyepharma
8.24.1 Skyepharma Comapny Information
8.24.2 Skyepharma Business Overview
8.24.3 Skyepharma Drug Delivery Devices Revenue and Gross Margin (2019-2024)
8.24.4 Skyepharma Drug Delivery Devices Product Portfolio
8.24.5 Skyepharma Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
LIST OF TABLES
Table 1. Drug Delivery Devices Industry Trends
Table 2. Drug Delivery Devices Industry Drivers
Table 3. Drug Delivery Devices Industry Opportunities and Challenges
Table 4. Drug Delivery Devices Industry Restraints
Table 5. Global Drug Delivery Devices Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Drug Delivery Devices Revenue Share by Company (2019-2024)
Table 7. Global Drug Delivery Devices Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global Drug Delivery Devices Key Company Manufacturing Base & Headquarters
Table 9. Global Drug Delivery Devices Company, Product Type & Application
Table 10. Global Drug Delivery Devices Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of Injection Type
Table 15. Major Companies of Mucosal Type
Table 16. Major Companies of Implanted Type
Table 17. Major Companies of Others Type
Table 18. Global Drug Delivery Devices Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Drug Delivery Devices Sales Value by Type (2019-2024) & (US$ Million)
Table 20. Global Drug Delivery Devices Sales Value by Type (2025-2030) & (US$ Million)
Table 21. Global Drug Delivery Devices Sales Value Share by Type (2019-2024)
Table 22. Global Drug Delivery Devices Sales Value Share by Type (2025-2030)
Table 23. Major Companies of Pharmaceutical Companies
Table 24. Major Companies of Hospitals
Table 25. Major Companies of Clinics
Table 26. Major Companies of Other
Table 27. Global Drug Delivery Devices Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 28. Global Drug Delivery Devices Sales Value by Application (2019-2024) & (US$ Million)
Table 29. Global Drug Delivery Devices Sales Value by Application (2025-2030) & (US$ Million)
Table 30. Global Drug Delivery Devices Sales Value Share by Application (2019-2024)
Table 31. Global Drug Delivery Devices Sales Value Share by Application (2025-2030)
Table 32. Global Drug Delivery Devices Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Drug Delivery Devices Sales Value by Region (2019-2024) & (US$ Million)
Table 34. Global Drug Delivery Devices Sales Value Share by Region (2019-2024)
Table 35. Global Drug Delivery Devices Sales Value by Region (2025-2030) & (US$ Million)
Table 36. Global Drug Delivery Devices Sales Value Share by Region (2025-2030)
Table 37. Global Drug Delivery Devices Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 38. Global Drug Delivery Devices Sales Value by Country (2019-2024) & (US$ Million)
Table 39. Global Drug Delivery Devices Sales Value Market Share by Country (2019-2024)
Table 40. Global Drug Delivery Devices Sales Value by Country (2025-2030) & (US$ Million)
Table 41. Global Drug Delivery Devices Sales Value Market Share by Country (2025-2030)
Table 42. Cipla Company Information
Table 43. Cipla Business Overview
Table 44. Cipla Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 45. Cipla Drug Delivery Devices Product Portfolio
Table 46. Cipla Recent Development
Table 47. Baxter International Company Information
Table 48. Baxter International Business Overview
Table 49. Baxter International Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 50. Baxter International Drug Delivery Devices Product Portfolio
Table 51. Baxter International Recent Development
Table 52. Nipro Corporation Company Information
Table 53. Nipro Corporation Business Overview
Table 54. Nipro Corporation Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 55. Nipro Corporation Drug Delivery Devices Product Portfolio
Table 56. Nipro Corporation Recent Development
Table 57. Roche Company Information
Table 58. Roche Business Overview
Table 59. Roche Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 60. Roche Drug Delivery Devices Product Portfolio
Table 61. Roche Recent Development
Table 62. Boehringer Ingelheim Company Information
Table 63. Boehringer Ingelheim Business Overview
Table 64. Boehringer Ingelheim Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 65. Boehringer Ingelheim Drug Delivery Devices Product Portfolio
Table 66. Boehringer Ingelheim Recent Development
Table 67. Allergan Company Information
Table 68. Allergan Business Overview
Table 69. Allergan Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 70. Allergan Drug Delivery Devices Product Portfolio
Table 71. Allergan Recent Development
Table 72. 3M Company Information
Table 73. 3M Business Overview
Table 74. 3M Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 75. 3M Drug Delivery Devices Product Portfolio
Table 76. 3M Recent Development
Table 77. BD Company Information
Table 78. BD Business Overview
Table 79. BD Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 80. BD Drug Delivery Devices Product Portfolio
Table 81. BD Recent Development
Table 82. Catalent Company Information
Table 83. Catalent Business Overview
Table 84. Catalent Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 85. Catalent Drug Delivery Devices Product Portfolio
Table 86. Catalent Recent Development
Table 87. Valeant Pharmaceuticals Company Information
Table 88. Valeant Pharmaceuticals Business Overview
Table 89. Valeant Pharmaceuticals Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 90. Valeant Pharmaceuticals Drug Delivery Devices Product Portfolio
Table 91. Valeant Pharmaceuticals Recent Development
Table 92. Bayer AG Company Information
Table 93. Bayer AG Business Overview
Table 94. Bayer AG Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Bayer AG Drug Delivery Devices Product Portfolio
Table 96. Bayer AG Recent Development
Table 97. Chiesi Company Information
Table 98. Chiesi Business Overview
Table 99. Chiesi Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Chiesi Drug Delivery Devices Product Portfolio
Table 101. Chiesi Recent Development
Table 102. Phillips-Medisize Company Information
Table 103. Phillips-Medisize Business Overview
Table 104. Phillips-Medisize Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Phillips-Medisize Drug Delivery Devices Product Portfolio
Table 106. Phillips-Medisize Recent Development
Table 107. Johnson & Johnson Company Information
Table 108. Johnson & Johnson Business Overview
Table 109. Johnson & Johnson Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Johnson & Johnson Drug Delivery Devices Product Portfolio
Table 111. Johnson & Johnson Recent Development
Table 112. Shandong Weigao Company Information
Table 113. Shandong Weigao Business Overview
Table 114. Shandong Weigao Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Shandong Weigao Drug Delivery Devices Product Portfolio
Table 116. Shandong Weigao Recent Development
Table 117. Pfizer Company Information
Table 118. Pfizer Business Overview
Table 119. Pfizer Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. Pfizer Drug Delivery Devices Product Portfolio
Table 121. Pfizer Recent Development
Table 122. B.Braun Company Information
Table 123. B.Braun Business Overview
Table 124. B.Braun Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. B.Braun Drug Delivery Devices Product Portfolio
Table 126. B.Braun Recent Development
Table 127. Novartis AG Company Information
Table 128. Novartis AG Business Overview
Table 129. Novartis AG Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Novartis AG Drug Delivery Devices Product Portfolio
Table 131. Novartis AG Recent Development
Table 132. Zhengkang Company Information
Table 133. Zhengkang Business Overview
Table 134. Zhengkang Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. Zhengkang Drug Delivery Devices Product Portfolio
Table 136. Zhengkang Recent Development
Table 137. Gerresheimer Company Information
Table 138. Gerresheimer Business Overview
Table 139. Gerresheimer Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 140. Gerresheimer Drug Delivery Devices Product Portfolio
Table 141. Gerresheimer Recent Development
Table 142. COVIDIEN Medtronic Company Information
Table 143. COVIDIEN Medtronic Business Overview
Table 144. COVIDIEN Medtronic Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 145. COVIDIEN Medtronic Drug Delivery Devices Product Portfolio
Table 146. COVIDIEN Medtronic Recent Development
Table 147. Schott forma vitrum Company Information
Table 148. Schott forma vitrum Business Overview
Table 149. Schott forma vitrum Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 150. Schott forma vitrum Drug Delivery Devices Product Portfolio
Table 151. Schott forma vitrum Recent Development
Table 152. Alkermes Company Information
Table 153. Alkermes Business Overview
Table 154. Alkermes Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 155. Alkermes Drug Delivery Devices Product Portfolio
Table 156. Alkermes Recent Development
Table 157. Skyepharma Company Information
Table 158. Skyepharma Business Overview
Table 159. Skyepharma Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 160. Skyepharma Drug Delivery Devices Product Portfolio
Table 161. Skyepharma Recent Development
Table 162. Research Programs/Design for This Report
Table 163. Authors List of This Report
Table 164. Secondary Sources
Table 165. Primary Sources
Table 1. Drug Delivery Devices Industry Trends
Table 2. Drug Delivery Devices Industry Drivers
Table 3. Drug Delivery Devices Industry Opportunities and Challenges
Table 4. Drug Delivery Devices Industry Restraints
Table 5. Global Drug Delivery Devices Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Drug Delivery Devices Revenue Share by Company (2019-2024)
Table 7. Global Drug Delivery Devices Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global Drug Delivery Devices Key Company Manufacturing Base & Headquarters
Table 9. Global Drug Delivery Devices Company, Product Type & Application
Table 10. Global Drug Delivery Devices Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of Injection Type
Table 15. Major Companies of Mucosal Type
Table 16. Major Companies of Implanted Type
Table 17. Major Companies of Others Type
Table 18. Global Drug Delivery Devices Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Drug Delivery Devices Sales Value by Type (2019-2024) & (US$ Million)
Table 20. Global Drug Delivery Devices Sales Value by Type (2025-2030) & (US$ Million)
Table 21. Global Drug Delivery Devices Sales Value Share by Type (2019-2024)
Table 22. Global Drug Delivery Devices Sales Value Share by Type (2025-2030)
Table 23. Major Companies of Pharmaceutical Companies
Table 24. Major Companies of Hospitals
Table 25. Major Companies of Clinics
Table 26. Major Companies of Other
Table 27. Global Drug Delivery Devices Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 28. Global Drug Delivery Devices Sales Value by Application (2019-2024) & (US$ Million)
Table 29. Global Drug Delivery Devices Sales Value by Application (2025-2030) & (US$ Million)
Table 30. Global Drug Delivery Devices Sales Value Share by Application (2019-2024)
Table 31. Global Drug Delivery Devices Sales Value Share by Application (2025-2030)
Table 32. Global Drug Delivery Devices Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Drug Delivery Devices Sales Value by Region (2019-2024) & (US$ Million)
Table 34. Global Drug Delivery Devices Sales Value Share by Region (2019-2024)
Table 35. Global Drug Delivery Devices Sales Value by Region (2025-2030) & (US$ Million)
Table 36. Global Drug Delivery Devices Sales Value Share by Region (2025-2030)
Table 37. Global Drug Delivery Devices Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 38. Global Drug Delivery Devices Sales Value by Country (2019-2024) & (US$ Million)
Table 39. Global Drug Delivery Devices Sales Value Market Share by Country (2019-2024)
Table 40. Global Drug Delivery Devices Sales Value by Country (2025-2030) & (US$ Million)
Table 41. Global Drug Delivery Devices Sales Value Market Share by Country (2025-2030)
Table 42. Cipla Company Information
Table 43. Cipla Business Overview
Table 44. Cipla Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 45. Cipla Drug Delivery Devices Product Portfolio
Table 46. Cipla Recent Development
Table 47. Baxter International Company Information
Table 48. Baxter International Business Overview
Table 49. Baxter International Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 50. Baxter International Drug Delivery Devices Product Portfolio
Table 51. Baxter International Recent Development
Table 52. Nipro Corporation Company Information
Table 53. Nipro Corporation Business Overview
Table 54. Nipro Corporation Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 55. Nipro Corporation Drug Delivery Devices Product Portfolio
Table 56. Nipro Corporation Recent Development
Table 57. Roche Company Information
Table 58. Roche Business Overview
Table 59. Roche Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 60. Roche Drug Delivery Devices Product Portfolio
Table 61. Roche Recent Development
Table 62. Boehringer Ingelheim Company Information
Table 63. Boehringer Ingelheim Business Overview
Table 64. Boehringer Ingelheim Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 65. Boehringer Ingelheim Drug Delivery Devices Product Portfolio
Table 66. Boehringer Ingelheim Recent Development
Table 67. Allergan Company Information
Table 68. Allergan Business Overview
Table 69. Allergan Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 70. Allergan Drug Delivery Devices Product Portfolio
Table 71. Allergan Recent Development
Table 72. 3M Company Information
Table 73. 3M Business Overview
Table 74. 3M Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 75. 3M Drug Delivery Devices Product Portfolio
Table 76. 3M Recent Development
Table 77. BD Company Information
Table 78. BD Business Overview
Table 79. BD Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 80. BD Drug Delivery Devices Product Portfolio
Table 81. BD Recent Development
Table 82. Catalent Company Information
Table 83. Catalent Business Overview
Table 84. Catalent Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 85. Catalent Drug Delivery Devices Product Portfolio
Table 86. Catalent Recent Development
Table 87. Valeant Pharmaceuticals Company Information
Table 88. Valeant Pharmaceuticals Business Overview
Table 89. Valeant Pharmaceuticals Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2019-2024)
Table 90. Valeant Pharmaceuticals Drug Delivery Devices Product Portfolio
Table 91. Valeant Pharmaceuticals Recent Development
Table 92. Bayer AG Company Information
Table 93. Bayer AG Business Overview
Table 94. Bayer AG Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Bayer AG Drug Delivery Devices Product Portfolio
Table 96. Bayer AG Recent Development
Table 97. Chiesi Company Information
Table 98. Chiesi Business Overview
Table 99. Chiesi Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Chiesi Drug Delivery Devices Product Portfolio
Table 101. Chiesi Recent Development
Table 102. Phillips-Medisize Company Information
Table 103. Phillips-Medisize Business Overview
Table 104. Phillips-Medisize Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Phillips-Medisize Drug Delivery Devices Product Portfolio
Table 106. Phillips-Medisize Recent Development
Table 107. Johnson & Johnson Company Information
Table 108. Johnson & Johnson Business Overview
Table 109. Johnson & Johnson Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Johnson & Johnson Drug Delivery Devices Product Portfolio
Table 111. Johnson & Johnson Recent Development
Table 112. Shandong Weigao Company Information
Table 113. Shandong Weigao Business Overview
Table 114. Shandong Weigao Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Shandong Weigao Drug Delivery Devices Product Portfolio
Table 116. Shandong Weigao Recent Development
Table 117. Pfizer Company Information
Table 118. Pfizer Business Overview
Table 119. Pfizer Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. Pfizer Drug Delivery Devices Product Portfolio
Table 121. Pfizer Recent Development
Table 122. B.Braun Company Information
Table 123. B.Braun Business Overview
Table 124. B.Braun Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. B.Braun Drug Delivery Devices Product Portfolio
Table 126. B.Braun Recent Development
Table 127. Novartis AG Company Information
Table 128. Novartis AG Business Overview
Table 129. Novartis AG Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Novartis AG Drug Delivery Devices Product Portfolio
Table 131. Novartis AG Recent Development
Table 132. Zhengkang Company Information
Table 133. Zhengkang Business Overview
Table 134. Zhengkang Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. Zhengkang Drug Delivery Devices Product Portfolio
Table 136. Zhengkang Recent Development
Table 137. Gerresheimer Company Information
Table 138. Gerresheimer Business Overview
Table 139. Gerresheimer Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 140. Gerresheimer Drug Delivery Devices Product Portfolio
Table 141. Gerresheimer Recent Development
Table 142. COVIDIEN Medtronic Company Information
Table 143. COVIDIEN Medtronic Business Overview
Table 144. COVIDIEN Medtronic Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 145. COVIDIEN Medtronic Drug Delivery Devices Product Portfolio
Table 146. COVIDIEN Medtronic Recent Development
Table 147. Schott forma vitrum Company Information
Table 148. Schott forma vitrum Business Overview
Table 149. Schott forma vitrum Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 150. Schott forma vitrum Drug Delivery Devices Product Portfolio
Table 151. Schott forma vitrum Recent Development
Table 152. Alkermes Company Information
Table 153. Alkermes Business Overview
Table 154. Alkermes Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 155. Alkermes Drug Delivery Devices Product Portfolio
Table 156. Alkermes Recent Development
Table 157. Skyepharma Company Information
Table 158. Skyepharma Business Overview
Table 159. Skyepharma Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 160. Skyepharma Drug Delivery Devices Product Portfolio
Table 161. Skyepharma Recent Development
Table 162. Research Programs/Design for This Report
Table 163. Authors List of This Report
Table 164. Secondary Sources
Table 165. Primary Sources
LIST OF FIGURES
Figure 1. Drug Delivery Devices Product Picture
Figure 2. Global Drug Delivery Devices Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Drug Delivery Devices Market Size (2019-2030) & (US$ Million)
Figure 4. Global Drug Delivery Devices Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. Injection Type Picture
Figure 8. Mucosal Type Picture
Figure 9. Implanted Type Picture
Figure 10. Others Type Picture
Figure 11. Global Drug Delivery Devices Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Drug Delivery Devices Sales Value Share 2019 VS 2023 VS 2030
Figure 13. Global Drug Delivery Devices Sales Value Share by Type (2019-2030)
Figure 14. Pharmaceutical Companies Picture
Figure 15. Hospitals Picture
Figure 16. Clinics Picture
Figure 17. Other Picture
Figure 18. Global Drug Delivery Devices Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Drug Delivery Devices Sales Value Share 2019 VS 2023 VS 2030
Figure 20. Global Drug Delivery Devices Sales Value Share by Application (2019-2030)
Figure 21. Global Drug Delivery Devices Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 22. Global Drug Delivery Devices Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 23. North America Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
Figure 24. North America Drug Delivery Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 25. Europe Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
Figure 26. Europe Drug Delivery Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 27. Asia-Pacific Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Drug Delivery Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 29. Latin America Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
Figure 30. Latin America Drug Delivery Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 31. Middle East & Africa Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
Figure 32. Middle East & Africa Drug Delivery Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 33. USA Drug Delivery Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 34. USA Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 35. USA Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 36. Canada Drug Delivery Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 37. Canada Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 38. Canada Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 39. Germany Drug Delivery Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 40. Germany Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 41. Germany Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 42. France Drug Delivery Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. France Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. France Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. U.K. Drug Delivery Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. U.K. Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. U.K. Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. Italy Drug Delivery Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. Italy Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. Italy Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. Netherlands Drug Delivery Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. Netherlands Drug Delivery Devices
Figure 1. Drug Delivery Devices Product Picture
Figure 2. Global Drug Delivery Devices Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Drug Delivery Devices Market Size (2019-2030) & (US$ Million)
Figure 4. Global Drug Delivery Devices Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. Injection Type Picture
Figure 8. Mucosal Type Picture
Figure 9. Implanted Type Picture
Figure 10. Others Type Picture
Figure 11. Global Drug Delivery Devices Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Drug Delivery Devices Sales Value Share 2019 VS 2023 VS 2030
Figure 13. Global Drug Delivery Devices Sales Value Share by Type (2019-2030)
Figure 14. Pharmaceutical Companies Picture
Figure 15. Hospitals Picture
Figure 16. Clinics Picture
Figure 17. Other Picture
Figure 18. Global Drug Delivery Devices Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Drug Delivery Devices Sales Value Share 2019 VS 2023 VS 2030
Figure 20. Global Drug Delivery Devices Sales Value Share by Application (2019-2030)
Figure 21. Global Drug Delivery Devices Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 22. Global Drug Delivery Devices Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 23. North America Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
Figure 24. North America Drug Delivery Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 25. Europe Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
Figure 26. Europe Drug Delivery Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 27. Asia-Pacific Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Drug Delivery Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 29. Latin America Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
Figure 30. Latin America Drug Delivery Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 31. Middle East & Africa Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
Figure 32. Middle East & Africa Drug Delivery Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 33. USA Drug Delivery Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 34. USA Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 35. USA Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 36. Canada Drug Delivery Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 37. Canada Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 38. Canada Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 39. Germany Drug Delivery Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 40. Germany Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 41. Germany Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 42. France Drug Delivery Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. France Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. France Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. U.K. Drug Delivery Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. U.K. Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. U.K. Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. Italy Drug Delivery Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. Italy Drug Delivery Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. Italy Drug Delivery Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. Netherlands Drug Delivery Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. Netherlands Drug Delivery Devices
